Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 5 | 1 |
| List of Figures | 5 | 1 |
| ChemoCentryx, Inc. Snapshot | 6 | 1 |
| ChemoCentryx, Inc. Overview | 6 | 1 |
| Key Facts | 6 | 1 |
| ChemoCentryx, Inc. Research and Development Overview | 7 | 4 |
| Key Therapeutic Areas | 7 | 4 |
| ChemoCentryx, Inc. Pipeline Review | 11 | 2 |
| Pipeline Products by Stage of Development | 11 | 1 |
| Pipeline Products Monotherapy | 12 | 1 |
| ChemoCentryx, Inc. Pipeline Products Glance | 13 | 5 |
| ChemoCentryx, Inc. Late Stage Pipeline Products | 13 | 1 |
| Phase III Products/Combination Treatment Modalities | 13 | 1 |
| ChemoCentryx, Inc. Clinical Stage Pipeline Products | 14 | 1 |
| Phase II Products/Combination Treatment Modalities | 14 | 1 |
| Phase I Products/Combination Treatment Modalities | 15 | 1 |
| ChemoCentryx, Inc. Early Stage Pipeline Products | 16 | 1 |
| Preclinical Products/Combination Treatment Modalities | 16 | 1 |
| Discovery Products/Combination Treatment Modalities | 17 | 1 |
| ChemoCentryx, Inc. Drug Profiles | 18 | 28 |
| CCR-23G Drug Profile | 18 | 1 |
| CCR-93G Drug Profile | 19 | 1 |
| CCX-140 Drug Profile | 20 | 4 |
| CCX-168 Drug Profile | 24 | 5 |
| CCX-354 Drug Profile | 29 | 2 |
| CCX-507 Drug Profile | 31 | 1 |
| CCX-6239 Drug Profile | 32 | 1 |
| CCX-650 Drug Profile | 33 | 1 |
| CCX-771 Drug Profile | 34 | 1 |
| CCX-872 Drug Profile | 35 | 2 |
| CCX-9588 Drug Profile | 37 | 1 |
| CCX-991 Drug Profile | 38 | 1 |
| Small Molecule to Antagonize CCR1 for Undisclosed Indication Drug Profile | 39 | 1 |
| Small Molecule to Antagonize CXCR6 for Autoimmune, Oncology and Liver Diseases Drug Profile | 40 | 1 |
| Small Molecule to Target C5aR for Undisclosed Indication Drug Profile | 41 | 1 |
| Small Molecules to Antagonize CCR and CXCR for Oncology and Autoimmune Disease Drug Profile | 42 | 1 |
| vercirnon sodium Drug Profile | 43 | 3 |
| ChemoCentryx, Inc. Pipeline Analysis | 46 | 6 |
| ChemoCentryx, Inc. Pipeline Products by Target | 46 | 2 |
| ChemoCentryx, Inc. Pipeline Products by Route of Administration | 48 | 1 |
| ChemoCentryx, Inc. Pipeline Products by Molecule Type | 49 | 1 |
| ChemoCentryx, Inc. Pipeline Products by Mechanism of Action | 50 | 2 |
| ChemoCentryx, Inc. Dormant Projects | 52 | 1 |
| ChemoCentryx, Inc. Discontinued Pipeline Products | 53 | 1 |
| Discontinued Pipeline Product Profiles | 53 | 1 |
| CCX-832 | 53 | 1 |
| vercirnon sodium | 53 | 1 |
| ChemoCentryx, Inc. Locations And Subsidiaries | 54 | 1 |
| Head Office | 54 | 1 |
| Other Locations &Subsidiaries | 54 | 1 |
| Appendix | 55 | 2 |
| Methodology | 55 | 1 |
| Coverage | 55 | 1 |
| Secondary Research | 55 | 1 |
| Primary Research | 55 | 1 |
| Expert Panel Validation | 55 | 1 |
| Contact Us | 55 | 1 |
| Disclaimer | 56 | 1 |